NUMEDII
NuMedii is a biotechnology company that discovers and de-risks effective new drugs by translating life sciences big data into therapies. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii. It utilizes hundreds of millions of raw human, biological, pharmacological, and clinical data points. The company was founded in 2008 and headquartered in San Mateo, California.
NUMEDII
Industry:
Biotechnology Medical Therapeutics
Founded:
2008-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.numedii.com
Total Employee:
11+
Status:
Active
Contact:
650-521-6363
Email Addresses:
[email protected]
Total Funding:
5.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins Google Apps For Business GoDaddy DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
Seraph Group
Seraph Group investment in Series A - NuMedii
TSVC
TSVC investment in Series A - NuMedii
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series A - NuMedii
StartX (Stanford-StartX Fund)
StartX (Stanford-StartX Fund) investment in Series A - NuMedii
Claremont Creek Ventures
Claremont Creek Ventures investment in Series A - NuMedii
Claremont Creek Ventures
Claremont Creek Ventures investment in Series A - NuMedii
Life Science Angels
Life Science Angels investment in Series A - NuMedii
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series A - NuMedii
Official Site Inspections
http://www.numedii.com Semrush global rank: 5.9 M Semrush visits lastest month: 1.4 K
- Host name: 181.0.153.160.host.secureserver.net
- IP address: 160.153.0.181
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "NuMedii"
NuMedii – Disrupting Drug Discovery Using Big Data and Artificial ...
AI · BIG DATA · PRECISION THERAPEUTICS Disrupting Drug Discovery Using Big Data & Artificial IntelligenceSee details»
NuMedii - Crunchbase Company Profile & Funding
NuMedii is a biotechnology company that discovers and de-risks effective new drugs by translating life sciences big data into therapies. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at …See details»
Technology - NuMedii
NuMedii has been pioneering the use of Big Data, Artificial Intelligence (AI) and systems biology since 2010 to accelerate the discovery of precision therapies to address high unmet medical needs.See details»
Leadership - NuMedii
As CEO of NuMedii, Gini structured the company’s critical partnerships with some of the world’s largest pharmaceutical companies including Allergan, Astellas and Aptalis, and raised the …See details»
NuMedii - VentureRadar
NuMedii has active R&D collaborations with several global pharmaceutical and biotech companies and patient-centric organizations to create pipeline and new products in multiple therapeutic …See details»
NuMedii, Inc. Company Profile | San Martin, CA | Competitors ...
Find company research, competitor information, contact details & financial data for NuMedii, Inc. of San Martin, CA. Get the latest business insights from Dun & Bradstreet.See details»
NuMedii Company Profile 2024: Valuation, Funding
Operator of a biotechnology company intended to address unmet medical needs.See details»
NuMedii - LinkedIn
NuMedii | 893 followers on LinkedIn. NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success.See details»
NuMedii Company Profile - Office Locations, Competitors ... - Craft
The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of …See details»
NuMedii - Company info. interviews, news - biopharmatrend.com
Sep 12, 2018 · The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of …See details»
NuMedii - Contacts, Employees, Board Members, Advisors & Alumni
NuMedii is a biotechnology company that discovers and de-risks effective drugs by translating life sciences big data into therapies.See details»
NuMedii - Overview, News & Similar companies | ZoomInfo.com
Jul 9, 2020 · NuMedii contact info: Phone number: (650) 918-6363 Website: www.numedii.com What does NuMedii do? NuMedii discovers effective new targets, drugs and biomarkers via its …See details»
Partners – NuMedii
NuMedii has active R&D collaborations with several global pharmaceutical and biotech companies and patient-centric organizations to create pipeline and new products through the use of our …See details»
NuMedii Forms Advisory Board for AI Approach to Personalized …
Jan 11, 2018 · NuMedii is advancing the field of personalized medicine for idiopathic pulmonary fibrosis (IPF) by creating a new advisory board that includes some of the world’s leading …See details»
NuMedii Collaborating With Experts to Develop Precision Therapies...
Jul 13, 2018 · NuMedii will collaborate with researchers at Yale School of Medicine and Brigham and Women’s Hospital to develop precision therapies and biomarkers for idiopathic pulmonary …See details»
Careers - NuMedii
At NuMedii, we have created a dynamic, collaborative and inclusive environment. Our team members are skilled in data sciences, machine learning, drug discovery and drug …See details»
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration …
Jan 15, 2020 · NuMedii's proprietary and dynamic AIDD (Artificial Intelligence for Drug Discovery) technology employs deep learnings of human biology consisting of hundreds of millions of …See details»
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration …
Jan 20, 2020 · NuMedii's proprietary and dynamic AIDD (Artificial Intelligence for Drug Discovery) technology employs deep learnings of human biology consisting of hundreds of millions of …See details»
Media – NuMedii
NuMedii Announces Creation of World’s First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators Press Release: Jan. 15, 2020 NuMedii, Inc. …See details»
NuMedii Announces New Indications Discovery Collaboration …
NuMedii, Inc., discovers effective new drugs by translating its predictive data intelligence technology into therapies with a higher probability of therapeutic success.See details»